ClinicalTrials.Veeva

Menu

P200TxE Diseased Eye Image Collection

Optos logo

Optos

Status

Enrolling

Conditions

Retinal Disease

Treatments

Device: P200TxE

Study type

Interventional

Funder types

Industry

Identifiers

NCT06269666
OPT1100

Details and patient eligibility

About

The primary objective is to collect images on the P200TxE device in diseased eyes.

Enrollment

100 estimated patients

Sex

All

Ages

22+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female subjects 22 years of age or older who have full legal capacity to subject on the date the informed consent is signed;
  2. Subjects who can follow the instructions by the clinical staff at the clinical site;
  3. Subjects who agree to participate;
  4. Subjects who have been diagnosed with retinal pathology and/or glaucoma that affects the posterior pole region including the macula and/or optic nerve.

For glaucoma subjects:

a. Glaucoma subjects who have a history of visual field loss and RNFL or optic nerve changes.

Exclusion criteria

  1. Subjects unable to tolerate ophthalmic imaging;
  2. Subjects with ocular media not sufficiently clear to obtain acceptable images.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Imaging Session
Other group
Description:
Various scans will be captured
Treatment:
Device: P200TxE

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems